Optimizing measurement of EGFR mutation status in NSCLC

被引：0
|
作者：
Nicolson, M.
Clark, C.
Bell, C.
Osborne, A.
Tracey, J.
Petty, R. D.
Kerr, K. M.
机构：
[1] Aberdeen Royal Infirm, Aberdeen, Scotland
[2] Univ Aberdeen, Aberdeen, Scotland
[3] Univ Aberdeen, Aberdeen Royal Infirm, Aberdeen, Scotland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e18120
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18120
引用
收藏
页数：1
相关论文
共 50 条
  • [31] EGFR mutation status in cerebrospinal fluid of NSCLC patients who developed leptomeningeal metastasis after EGFR-TKI treatment
    Zhao, Jing
    Ye, Xin
    Sun, Yun
    Yang, Zhenfan
    Zhu, Guanshan
    Chen, Minjiang
    Zhong, Wei
    Xu, Yan
    Zhang, Li
    Li, Longyun
    Xiao, Yi
    Wang, Mengzhao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] Clinical Outcomes After First-line EGFR Inhibitor Treatment for Patients with NSCLC, EGFR Mutation, and Poor Performance Status
    Okuma, Yusuke
    Hosomi, Yukio
    Nagamata, Makoto
    Yamada, Yuko
    Sekihara, Kuniko
    Kato, Kan
    Hishima, Tsunekazu
    Okamura, Tatsuru
    [J]. ANTICANCER RESEARCH, 2013, 33 (11) : 5057 - 5064
  • [33] EGFR mutation analysis from REASON: A registry for the epidemiologic and scientific evaluation of EGFR mutation status in newly diagnosed NSCLC patients stage IIIB/IV.
    Schuette, Wolfgang
    Eberhardt, Wilfried Ernst Erich
    von der Schulenburg, J. -Mathias Graf
    Dietel, Manfred
    Schirmacher, Peter
    Zaun, Silke
    Thomas, Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [34] Heterogeneous distribution of EGFR mutation in NSCLC: Case report
    Boukansa, Sara
    Benbrahim, Zineb
    Gamrani, Sanaa
    Mouhrach, Ismail
    El Agy, Fatima
    El Bardai, Sanae
    Bouguenouch, Laila
    Serraj, Mounia
    Amara, Bouchra
    Ouadnouni, Yassine
    Smahi, Mohamed
    Alami, Badreeddine
    Mellas, Nawfel
    El Fatemi, Hinde
    [J]. RESPIRATORY MEDICINE CASE REPORTS, 2023, 44
  • [35] EGFR mutation detection in NSCLC—assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC
    Roland Penzel
    Christine Sers
    Yuan Chen
    Ulrich Lehmann-Mühlenhoff
    Sabine Merkelbach-Bruse
    Andreas Jung
    Thomas Kirchner
    Reinhard Büttner
    Hans H. Kreipe
    Iver Petersen
    Manfred Dietel
    Peter Schirmacher
    [J]. Virchows Archiv, 2011, 458 : 95 - 98
  • [36] Radiomics for Detection of the EGFR Mutation in Liver Metastatic NSCLC
    Hou, Shaoping
    Fan, Ying
    Wang, Xiaoyu
    Su, Juan
    Ren, Meihong
    Wu, Yujiao
    Zhou, Jie
    Qu, Minghui
    Luo, Yahong
    Jiang, Wenyan
    [J]. ACADEMIC RADIOLOGY, 2023, 30 (06) : 1039 - 1046
  • [37] Osimertinib in EGFR Mutation-Positive Advanced NSCLC
    Roca, Elisa
    Amoroso, Vito
    Berruti, Alfredo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13): : 1261 - 1262
  • [38] EGFR mutation analysis in NSCLC: improving the testing rate
    Ho, A. L. K.
    Win, T.
    [J]. LUNG CANCER, 2014, 83 : S8 - S9
  • [39] Prognostic value of EGFR mutation in NSCLC in surgical stage
    Goncalves, Ana
    Antunes, Ana
    Campainha, Sergio
    Barroso, Ana
    Conde, Sara
    Miranda, Jose
    Parente, Barbara
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [40] EGFR MUTATION IN AUSTRIAN PATIENTS WITH NSCLC: A RETROSPECTIVE STUDY
    Hochmair, M. J.
    Miler, M.
    Setinek, U.
    Kirchbacher, K.
    Mohn-Staudner, A.
    Kaufmann, M.
    Kapfhammer, I.
    Arns, M. B.
    Patocka, K.
    Burghuber, O. C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S66 - S66
12345